Lorenzen A - Search Results

1

N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor.

Vittori S, Lorenzen A, Stannek C, Costanzi S, Volpini R, IJzerman AP, Kunzel JK, Cristalli G. Vittori S, et al. Among authors: lorenzen a. J Med Chem. 2000 Jan 27;43(2):250-60. doi: 10.1021/jm9911231. J Med Chem. 2000. PMID: 10649980

2

5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor.

van der Wenden EM, Carnielli M, Roelen HC, Lorenzen A, von Frijtag Drabbe Künzel JK, IJzerman AP. van der Wenden EM, et al. Among authors: lorenzen a. J Med Chem. 1998 Jan 1;41(1):102-8. doi: 10.1021/jm970508l. J Med Chem. 1998. PMID: 9438026

3

N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor.

van Tilburg EW, von Frijtag Drabbe Künzel J, de Groote M, Vollinga RC, Lorenzen A, IJzerman AP. van Tilburg EW, et al. Among authors: lorenzen a. J Med Chem. 1999 Apr 22;42(8):1393-400. doi: 10.1021/jm981090+. J Med Chem. 1999. PMID: 10212125

4

Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor.

Volpini R, Costanzi S, Lambertucci C, Vittori S, Klotz K, Lorenzen A, Cristalli G. Volpini R, et al. Among authors: lorenzen a. Bioorg Med Chem Lett. 2001 Jul 23;11(14):1931-4. doi: 10.1016/s0960-894x(01)00347-x. Bioorg Med Chem Lett. 2001. PMID: 11459663

5

5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors.

van Tilburg EW, van der Klein PA, von Frijtag Drabbe Künzel J, de Groote M, Stannek C, Lorenzen A, IJzerman AP. van Tilburg EW, et al. Among authors: lorenzen a. J Med Chem. 2001 Aug 30;44(18):2966-75. doi: 10.1021/jm001114o. J Med Chem. 2001. PMID: 11520205

6

Pyrazole derivatives as partial agonists for the nicotinic acid receptor.

van Herk T, Brussee J, van den Nieuwendijk AM, van der Klein PA, IJzerman AP, Stannek C, Burmeister A, Lorenzen A. van Herk T, et al. Among authors: lorenzen a. J Med Chem. 2003 Aug 28;46(18):3945-51. doi: 10.1021/jm030888c. J Med Chem. 2003. PMID: 12930155

7

Biological activities of N6,C8-disubstituted adenosine derivatives as partial agonists at rat brain adenosine A1 receptors.

Lorenzen A, Sebastião AM, Sellink A, Vogt H, Schwabe U, Ribeiro JA, IJzerman AP. Lorenzen A, et al. Eur J Pharmacol. 1997 Sep 10;334(2-3):299-307. doi: 10.1016/s0014-2999(97)01193-x. Eur J Pharmacol. 1997. PMID: 9369361

8

Synthesis and biological evaluation of disubstituted N6-cyclopentyladenine analogues: the search for a neutral antagonist with high affinity for the adenosine A1 receptor.

de Ligt RA, van der Klein PA, von Frijtag Drabbe Künzel JK, Lorenzen A, Ait El Maate F, Fujikawa S, van Westhoven R, van den Hoven T, Brussee J, IJzerman AP. de Ligt RA, et al. Among authors: lorenzen a. Bioorg Med Chem. 2004 Jan 2;12(1):139-49. doi: 10.1016/j.bmc.2003.10.023. Bioorg Med Chem. 2004. PMID: 14697779

9

A "locked-on," constitutively active mutant of the adenosine A1 receptor.

de Ligt RA, Rivkees SA, Lorenzen A, Leurs R, IJzerman AP. de Ligt RA, et al. Among authors: lorenzen a. Eur J Pharmacol. 2005 Mar 7;510(1-2):1-8. doi: 10.1016/j.ejphar.2005.01.007. Eur J Pharmacol. 2005. PMID: 15740718

10

Modulation of agonist responses at the A(1) adenosine receptor by an irreversible antagonist, receptor-G protein uncoupling and by the G protein activation state.

Lorenzen A, Beukers MW, van der Graaf PH, Lang H, van Muijlwijk-Koezen J, de Groote M, Menge W, Schwabe U, IJzerman AP. Lorenzen A, et al. Biochem Pharmacol. 2002 Oct 15;64(8):1251-65. doi: 10.1016/s0006-2952(02)01293-5. Biochem Pharmacol. 2002. PMID: 12234606

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

81 results

Search Page